Citrus flavonoids repress the mRNA for stearoyl-CoA desaturase, a key enzyme in lipid synthesis and obesity control, in rat primary hepatocytes

被引：34
作者：
Nichols L.A. [1 ]
Jackson D.E. [1 ]
Manthey J.A. [2 ]
Shukla S.D. [1 ]
Holland L.J. [1 ]
机构：
[1] Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia
[2] United States Department of Agriculture, Agricultural Research Service, Citrus and Subtropical Products Laboratory, Winter Haven
来源：
Lipids in Health and Disease | / 10卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Flavonoid; HepG2 Cell; Naringenin; Hesperetin; Sterol Regulatory Element Binding Protein;
D O I：
10.1186/1476-511X-10-36
中图分类号：
学科分类号：
摘要：
Citrus flavonoids have been shown to decrease plasma lipid levels, improve glucose tolerance, and attenuate obesity. One possible mechanism underlying these physiological effects is reduction of hepatic levels of the mRNA for stearoyl-CoA desaturase-1 (SCD1), since repression of this enzyme reduces hyperlipidemia and adiposity. Here, we show that citrus flavonoids of two structural classes reduce SCD1 mRNA concentrations in a dose-dependent manner in rat primary hepatocytes. This is the first demonstration of repression of SCD1 by citrus flavonoids, either in vivo or in cultured cells. Furthermore, it is the first use of freshly-isolated hepatocytes from any animal to examine citrus flavonoid action at the mRNA level. This study demonstrates that regulation of SCD1 gene expression may play a role in control of obesity by citrus flavonoids and that rat primary hepatocytes are a physiologically-relevant model system for analyzing the molecular mechanisms of flavonoid action in the liver. © 2011 Nichols et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 35 条
  • [1] Dobrzyn A., Ntambi J.M., Stearoyl-CoA desaturase as a new drug target for obesity treatment, Obesity Reviews, 6, 2, pp. 169-174, (2005)
  • [2] Sampath H., Miyazaki M., Dobrzyn A., Ntambi J.M., Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat, Journal of Biological Chemistry, 282, 4, pp. 2483-2493, (2007)
  • [3] Jiang G., Li Z., Liu F., Ellsworth K., Dallas-Yang Q., Wu M., Ronan J., Esau C., Murphy C., Szalkowski D., Bergeron R., Doebber T., Zhang B.B., Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1, Journal of Clinical Investigation, 115, 4, pp. 1030-1038, (2005)
  • [4] Gutierrez-Jurez R., Pocai A., Mulas C., Ono H., Bhanot S., Monia B.P., Rossetti L., Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance, J Clin Invest, 116, pp. 1686-1695, (2006)
  • [5] Miyazaki M., Flowers M.T., Sampath H., Chu K., Otzelberger C., Liu X., Ntambi J.M., Hepatic Stearoyl-CoA Desaturase-1 Deficiency Protects Mice from Carbohydrate-Induced Adiposity and Hepatic Steatosis, Cell Metabolism, 6, 6, pp. 484-496, (2007)
  • [6] Flowers M.T., Ntambi J.M., Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity, Biochim Biophys Acta, 1791, pp. 85-91, (2009)
  • [7] Attie A.D., Krauss R.M., Gray-Keller M.P., Brownlie A., Miyazaki M., Kastelein J.J., Lusis A.J., Stalenhoef A.F.H., Stoehr J.P., Hayden M.R., Ntambi J.M., Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia, Journal of Lipid Research, 43, 11, pp. 1899-1907, (2002)
  • [8] Mar-Heyming R., Miyazaki M., Weissglas-Volkov D., Kolaitis N.A., Sadaat N., Plaisier C., Pajukanta P., Cantor R.M., De Bruin T.W.A., Ntambi J.M., Lusis A.J., Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia, Arterioscler Thromb Vasc Biol, 28, pp. 1193-1199, (2008)
  • [9] Chong M.F.-F., Hodson L., Bickerton A.S., Roberts R., Neville M., Karpe F., Frayn K.N., Fielding B.A., Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding, American Journal of Clinical Nutrition, 87, 4, pp. 817-823, (2008)
  • [10] Gorinstein S., Caspi A., Libman I., Katrich E., Lerner H.T., Trakhtenberg S., Preventive effects of diets supplemented with sweetie fruits in hypercholesterolemic patients suffering from coronary artery disease, Preventive Medicine, 38, 6, pp. 841-847, (2004)
1234